BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10590082)

  • 1. T-Cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires.
    Godthelp BC; van Tol MJ; Vossen JM; van Den Elsen PJ
    Blood; 1999 Dec; 94(12):4358-69. PubMed ID: 10590082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term T cell immune reconstitution in 2 SCID patients after BMT.
    Godthelp BC; van Tol MJ; Vossen JM; van den Elsen PJ
    Hum Immunol; 1998 Apr; 59(4):225-38. PubMed ID: 9568798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal analysis of T cells responding to tetanus toxoid in healthy subjects as well as in pediatric patients after bone marrow transplantation: the identification of identical TCR-CDR3 regions in time suggests long-term stability of at least part of the antigen-specific TCR repertoire.
    Godthelp BC; van Tol MJ; Vossen JM; van den Elsen PJ
    Int Immunol; 2001 Apr; 13(4):507-18. PubMed ID: 11282990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Sun AN; Feng YF; Chang WR; Zhu ZL; Zhu P
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):312-7. PubMed ID: 17877159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDR3 and V genes show distinct reconstitution patterns in T cell repertoire post-allogeneic bone marrow transplantation.
    Tickotsky-Moskovitz N; Louzoun Y; Dvorkin S; Rotkopf A; Kuperman AA; Efroni S
    Immunogenetics; 2021 Apr; 73(2):163-173. PubMed ID: 33475766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete T-cell immune reconstitution in two major histocompatibility complex class II-deficiency/bare lymphocyte syndrome patients after HLA-identical sibling bone marrow transplantation.
    Godthelp BC; van Eggermond MC; Peijnenburg A; Tezcan I; van Lierde S; van Tol MJ; Vossen JM; van den Elsen PJ
    Blood; 1999 Jul; 94(1):348-58. PubMed ID: 10381532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
    Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
    Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.
    Wu CJ; Chillemi A; Alyea EP; Orsini E; Neuberg D; Soiffer RJ; Ritz J
    Blood; 2000 Jan; 95(1):352-9. PubMed ID: 10607724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW; Wu DP; Cen JN; Feng YF; Chang WR; Qiu QC; Zhu ZL; Zhu P
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2265-7. PubMed ID: 18001548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire.
    Verfuerth S; Peggs K; Vyas P; Barnett L; O'Reilly RJ; Mackinnon S
    Blood; 2000 Jun; 95(12):3990-5. PubMed ID: 10845939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the pattern of TCR V beta repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans.
    Lonial S; Bomberger C; Waller EK
    Br J Haematol; 2001 Apr; 113(1):224-30. PubMed ID: 11328305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stromal cell line co-transfected with IL-2 and IL-3 genes can accelerate restoration of T-cell immunity in allo-BMT mice.
    Li AL; Jiang JY; Ma JB; Wang GM; Hao J; Gao X; Xie SS
    Chin Med J (Engl); 2004 Aug; 117(8):1223-7. PubMed ID: 15361299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.
    Keever CA; Small TN; Flomenberg N; Heller G; Pekle K; Black P; Pecora A; Gillio A; Kernan NA; O'Reilly RJ
    Blood; 1989 Apr; 73(5):1340-50. PubMed ID: 2649174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted usage of T-cell receptor alpha-chain variable region (TCRAV) and T-cell receptor beta-chain variable region (TCRBV) repertoires after human allogeneic haematopoietic transplantation.
    Matsutani T; Yoshioka T; Tsuruta Y; Iwagami S; Toyosaki-Maeda T; Horiuchi T; Miura AB; Watanabe A; Takada G; Suzuki R; Hirokawa M
    Br J Haematol; 2000 Jun; 109(4):759-69. PubMed ID: 10929026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
    Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow-bone marrow transplantation plus fetal thymus transplantation.
    Hosaka N; Cui W; Zhang Y; Takaki T; Inaba M; Ikehara S
    Cancer Immunol Immunother; 2010 Jul; 59(7):1121-30. PubMed ID: 20229083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
    Meier JA; Haque M; Fawaz M; Abdeen H; Coffey D; Towlerton A; Abdeen A; Toor A; Warren E; Reed J; Kanakry CG; Keating A; Luznik L; Toor AA
    Biol Blood Marrow Transplant; 2019 May; 25(5):868-882. PubMed ID: 30677510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
    Eyrich M; Leiler C; Lang P; Schilbach K; Schumm M; Bader P; Greil J; Klingebiel T; Handgretinger R; Niethammer D; Schlegel PG
    Bone Marrow Transplant; 2003 Aug; 32(4):379-90. PubMed ID: 12900774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.